New Frontier in Combatting Cervical Cancer


NEW FRONTIER IN RADIOTHERAPY FOR CERVICAL CANCER

Assistant Professor Chomporn Sitathanee, MD

Department of Radiology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand


SYNOPSIS

Cervical cancer is the second leading cancer in Thai women. Radiotherapy can be used as a curative treatment (definitive, adjuvant/postoperative) or palliative treatment. Curative treatment consists of external-beam radiation, brachytherapy, and most of the time, concurrent platinum-based chemotherapy. New developments in both external-beam radiation and brachytherapy aim to improve tumor control and reduce treatment complications. Advanced imaging techniques including CT scan, MRI, and PET/CT, that help us better define initial disease extension, in combination with intensity-modulated radiotherapy (IMRT) and image-guided adaptive brachytherapy (intracavitary and interstitial insertion) have been shown to increase radiation dose to the targets and reduce normal tissue toxicity. Intensification of concurrent or sequential systemic therapy is under evaluation.

Event Hours(1)

  • Convention Hall A.

    01:00 pm – 02:30 pm

    Speakers:
    1. Asst. Prof. Chomporn Sitathanee (Rama)
    2. Assoc. Prof. Irene Ruengkhacharm (SI)
    3. Dr. Nuttavut Kantathavorn (CRA)
    4. Assoc. Prof. Wichai Termrungruanglert (CU)

    Moderator:
    Assoc. Prof. Arbaroon Lertkhachonsuk (Rama)